Jiwei Shen
Shenyang, 110036, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Structural characterization, controlled enzymatic hydrolysis and immunomodulatory activities of three ginseng polysaccharides.
Journal: Carbohydrate research
Published: April 24, 2026
Recent advances in Pyrazolo[3,4-d]pyrimidine-based dual inhibitors in the treatment of cancers.
Journal: Molecular diversity
Published: June 11, 2025
Structural characteristics and SARs of EZH2 inhibitors.
Journal: Molecular diversity
Published: April 29, 2025
Advances in Drug Therapy for Gastrointestinal Stromal Tumour.
Journal: Current medicinal chemistry
Published: October 03, 2022
Application and SARs of Pyrazolo[1,5-a]pyrimidine as Antitumor Agents Scaffold.
Journal: Current topics in medicinal chemistry
Published: June 29, 2022
Corrigendum to "5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-((4-methylpiperazin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)phenyl)pyrimidine-2,4-diamine (WY-135), a novel ALK inhibitor, induces cell cycle arrest and apoptosis through inhibiting ALK and its downstream pathways in Karpas299 and H2228 cells" [Chem. Biol. Interact. 284 (2018) 24-31].
Journal: Chemico-biological interactions
Published: March 03, 2022
Research Progress on Small Molecules Inhibitors Targeting TRK Kinases.
Journal: Current medicinal chemistry
Published: January 08, 2022
EML4-ALK G1202R mutation induces EMT and confers resistance to ceritinib in NSCLC cells via activation of STAT3/Slug signaling.
Journal: Cellular signalling
Published: August 23, 2021
1-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)-3-(2-(dimethylamino)ethyl)imidazolidin-2-one (ZX-42), a novel ALK inhibitor, induces apoptosis and protective autophagy in H2228 cells.
Journal: The Journal of pharmacy and pharmacology
Published: January 13, 2020
ZX-29, a novel ALK inhibitor, induces apoptosis via ER stress in ALK rearrangement NSCLC cells and overcomes cell resistance caused by an ALK mutation.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: September 12, 2019
A novel ALK inhibitor ZYY inhibits Karpas299 cell growth in vitro and in a mouse xenograft model and induces protective autophagy.
Journal: Toxicology and applied pharmacology
Published: May 24, 2019
CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib.
Journal: Cancer letters
Published: November 29, 2017
Last Updated: 09/26/2026